Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


Articles published in J Surg Oncol

Retrieve available abstracts of 49 articles:
HTML format
Text format



Single Articles


    June 2018
  1. BEVERIDGE J, Taher M, Zhu J, Mahmood MN, et al
    Staged margin-controlled excision (SMEX) for lentigo maligna melanoma in situ.
    J Surg Oncol. 2018 Jun 24. doi: 10.1002/jso.25109.
    PubMed     Text format     Abstract available


  2. ROBINSON EM, Rosenbaum BE, Zhang Y, Rogers R, et al
    Association between Ki-67 expression and clinical outcomes among patients with clinically node-negative, thick primary melanoma who underwent nodal staging.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25111.
    PubMed     Text format     Abstract available


    April 2018
  3. BOONE BA, Perkins S, Bandi R, Santos E, et al
    Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma.
    J Surg Oncol. 2018;117:940-946.
    PubMed     Text format     Abstract available


  4. POSSO C, Delgado Anaya D, Aguilar Henao J, Velasquez Gaviria JM, et al
    Nasolabial propeller perforator flap: Anatomical study and case series.
    J Surg Oncol. 2018;117:1100-1106.
    PubMed     Text format     Abstract available


    March 2018
  5. READ TA, Smith A, Thomas J, David M, et al
    Intralesional PV-10 for the treatment of in-transit melanoma metastases-Results of a prospective, non-randomized, single center study.
    J Surg Oncol. 2018 Mar 12. doi: 10.1002/jso.24921.
    PubMed     Text format     Abstract available


  6. PUZA CJ, Josyula S, Terando AM, Howard JH, et al
    Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma?
    J Surg Oncol. 2018 Mar 7. doi: 10.1002/jso.25025.
    PubMed     Text format     Abstract available


  7. PUSIOL T, Piscioli F
    Management of thin melanoma.
    J Surg Oncol. 2018 Mar 6. doi: 10.1002/jso.24863.
    PubMed     Text format    


  8. HUGHES T, Broucek J, Iodice G, Bommareddy PK, et al
    Metastasectomy following incomplete response to high-dose interleukin-2.
    J Surg Oncol. 2018;117:572-578.
    PubMed     Text format     Abstract available


    February 2018
  9. BRANDAO PHDM, Bertolli E, Doria-Filho E, Santos Filho IDAO, et al
    In transit sentinel node drainage as a prognostic factor for patients with cutaneous melanoma.
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25023.
    PubMed     Text format     Abstract available


  10. LOOK HONG NJ
    Melanoma patterns of care in Ontario: A call for a strategic alignment of multidisciplinary care-Response to letter.
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25006.
    PubMed     Text format    


  11. MARUCCIA M, Elia R, Nacchiero E, Vestita M, et al
    Reply to "melanoma pattern of care in ontario: A call for strategic alignment of multidisciplinary care)".
    J Surg Oncol. 2018 Feb 15. doi: 10.1002/jso.25007.
    PubMed     Text format    


    December 2017
  12. KARYDIS I, Gangi A, Wheater MJ, Choi J, et al
    Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.
    J Surg Oncol. 2017 Dec 28. doi: 10.1002/jso.24956.
    PubMed     Text format     Abstract available


  13. SUN H, Gong L, Zhao G, Zhan H, et al
    Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus.
    J Surg Oncol. 2017 Dec 19. doi: 10.1002/jso.24905.
    PubMed     Text format     Abstract available


  14. LOOK HONG NJ, Cheng SY, Baxter NN, Wright FC, et al
    Melanoma patterns of care in Ontario: A call for a strategic alignment of multidisciplinary care.
    J Surg Oncol. 2017 Dec 11. doi: 10.1002/jso.24936.
    PubMed     Text format     Abstract available


  15. JAKUB JW, Racz JM, Hieken TJ, Gonzalez AB, et al
    Neoadjuvant systemic therapy for regionally advanced melanoma.
    J Surg Oncol. 2017 Dec 11. doi: 10.1002/jso.24939.
    PubMed     Text format     Abstract available


  16. LORIMER PD, Benham E, Walsh K, Han Y, et al
    Letter response: Reporting of mitotic rate in cutaneous melanoma.
    J Surg Oncol. 2017;116:960.
    PubMed     Text format    


  17. CHU BS, Koffi W, Hoehn RS, Ertel A, et al
    Improvement and persistent disparities in completion lymph node dissection: Lessons from the National Cancer Database.
    J Surg Oncol. 2017;116:1176-1184.
    PubMed     Text format     Abstract available


    November 2017
  18. HERBERT G, Karakousis GC, Bartlett EK, Zaheer S, et al
    Transected thin melanoma: Implications for sentinel lymph node staging.
    J Surg Oncol. 2017 Nov 30. doi: 10.1002/jso.24930.
    PubMed     Text format     Abstract available


  19. DURHAM AB, Schwartz JL, Lowe L, Zhao L, et al
    In reply: Management of thin melanoma.
    J Surg Oncol. 2017 Nov 11. doi: 10.1002/jso.24858.
    PubMed     Text format    


    July 2017
  20. DURHAM AB, Schwartz JL, Lowe L, Zhao L, et al
    The natural history of thin melanoma and the utility of sentinel lymph node biopsy.
    J Surg Oncol. 2017 Jul 17. doi: 10.1002/jso.24765.
    PubMed     Text format     Abstract available


    June 2017
  21. RONCATI L, Piscioli F, Pusiol T
    The importance of mitotic rate reporting in primary cutaneous melanoma.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24738.
    PubMed     Text format    


  22. SUH YC, Suh HP, Lee JS, Chang JS, et al
    Reconstruction using a perforator free flap after malignant melanoma resection of the ankle and foot.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24736.
    PubMed     Text format     Abstract available


  23. ZIPPEL D, Markel G, Shapira-Frommer R, Ben-Betzalel G, et al
    Perioperative BRAF inhibitors in locally advanced stage III melanoma.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24744.
    PubMed     Text format     Abstract available


  24. SINNAMON AJ, Neuwirth MG, Bartlett EK, Zaheer S, et al
    Predictors of false negative sentinel lymph node biopsy in trunk and extremity melanoma.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24743.
    PubMed     Text format     Abstract available


    May 2017
  25. OZAO-CHOY J, Nelson DW, Hiles J, Stern S, et al
    The prognostic importance of scalp location in primary head and neck melanoma.
    J Surg Oncol. 2017 May 22. doi: 10.1002/jso.24679.
    PubMed     Text format     Abstract available


    April 2017
  26. MADU MF, Schopman JHH, Berger DMS, Klop WMC, et al
    Clinical prognostic markers in stage IIIC melanoma.
    J Surg Oncol. 2017 Apr 15. doi: 10.1002/jso.24635.
    PubMed     Text format     Abstract available


    March 2017
  27. LORIMER PD, Benham EC, Walsh K, Han Y, et al
    Reporting of mitotic rate in cutaneous melanoma: A study using the national cancer data base.
    J Surg Oncol. 2017;115:281-286.
    PubMed     Text format     Abstract available


    February 2017
  28. FOOTE M, Read T, Thomas J, Wagels M, et al
    Results of a phase II, open-label, non-comparative study of intralesional PV-10 followed by radiotherapy for the treatment of in-transit or metastatic melanoma.
    J Surg Oncol. 2017 Feb 23. doi: 10.1002/jso.24580.
    PubMed     Text format     Abstract available


    December 2016
  29. SPARKS DS, Read T, Lonne M, Barbour AP, et al
    Primary cutaneous melanoma of the scalp: Patterns of recurrence.
    J Surg Oncol. 2016 Dec 30. doi: 10.1002/jso.24535.
    PubMed     Text format     Abstract available


    September 2016
  30. LEE KT, Kim EJ, Lee DY, Kim JH, et al
    Surgical excision margin for primary acral melanoma.
    J Surg Oncol. 2016 Sep 19. doi: 10.1002/jso.24442.
    PubMed     Text format     Abstract available


  31. DINH KH, Harris AF, LaFemina J, Whalen GF, et al
    Advantages of day-before lymphoscintigraphy and undiluted methylene blue dye injections for sentinel lymph node biopsies for melanoma.
    J Surg Oncol. 2016 Sep 16. doi: 10.1002/jso.24432.
    PubMed     Text format     Abstract available


  32. FAHY AS, Grotz TE, Keeney GL, Glasgow AE, et al
    Frozen section analysis of SLNs in trunk and extremity melanoma has a high false negative rate but can spare some patients a second operation.
    J Surg Oncol. 2016 Sep 16. doi: 10.1002/jso.24430.
    PubMed     Text format     Abstract available


    July 2016
  33. LIU JB, Bilimoria KY
    Weighing the value of completion nodal dissection for melanoma.
    J Surg Oncol. 2016 Jul 22. doi: 10.1002/jso.24273.
    PubMed     Text format     Abstract available


    June 2016
  34. CHANG TN, Lee CH, Lai CH, Wu CW, et al
    Profunda artery perforator flap for isolated vulvar defect reconstruction after oncological resection.
    J Surg Oncol. 2016;113:828-34.
    PubMed     Text format     Abstract available


    May 2016
  35. LIPPEY J, Bousounis R, Behrenbruch C, McKay B, et al
    Intralesional PV-10 for in-transit melanoma-A single-center experience.
    J Surg Oncol. 2016 May 30. doi: 10.1002/jso.24311.
    PubMed     Text format     Abstract available


    March 2016
  36. NICHOLL MB, Chen X, Qin C, Bai Q, et al
    IL-32alpha has differential effects on proliferation and apoptosis of human melanoma cell lines.
    J Surg Oncol. 2016;113:364-369.
    PubMed     Text format     Abstract available


    December 2015
  37. ETHUN CG, Delman KA
    The importance of surgical margins in melanoma.
    J Surg Oncol. 2015 Dec 10. doi: 10.1002/jso.24111.
    PubMed     Text format     Abstract available


  38. DOEPKER MP, Thompson ZJ, Harb JN, Messina JL, et al
    Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy.
    J Surg Oncol. 2015 Dec 10. doi: 10.1002/jso.24088.
    PubMed     Text format     Abstract available


  39. HOWIE LJ, Tyler DS, Salama AK
    Neoadjuvant use of ipilimumab in locally advanced melanoma.
    J Surg Oncol. 2015;112:841-3.
    PubMed     Text format     Abstract available


    October 2015
  40. FLAHERTY DC, Hoffner BW, Lau BJ, Hamid O, et al
    Hepatic hemorrhage as a consequence of rapid response to combined targeted therapy in metastatic melanoma.
    J Surg Oncol. 2015 Oct 26. doi: 10.1002/jso.24078.
    PubMed     Text format     Abstract available


  41. VOSS RK, Cromwell KD, Chiang YJ, Armer JM, et al
    The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patients.
    J Surg Oncol. 2015 Oct 18. doi: 10.1002/jso.24068.
    PubMed     Text format     Abstract available


    August 2015
  42. SMITHERS BM, Hughes MC, Beesley VL, Barbour AP, et al
    Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk of spread, in Queensland, Australia.
    J Surg Oncol. 2015 Aug 27. doi: 10.1002/jso.24013.
    PubMed     Text format     Abstract available


  43. SABEL MS, Lee J, Wang A, Lao C, et al
    Morphomics predicts response to ipilimumab in patients with stage IV melanoma.
    J Surg Oncol. 2015 Aug 7. doi: 10.1002/jso.24003.
    PubMed     Text format     Abstract available


  44. RIVARD J, Kostaras X, Shea-Budgell M, Chin-Lenn L, et al
    A population-based assessment of melanoma: Does treatment in a regional cancer center make a difference?
    J Surg Oncol. 2015;112:173-8.
    PubMed     Text format     Abstract available


  45. FARLEY C, Alimi Y, Espinosa LR, Perez S, et al
    Tanning beds: A call to action for further educational and legislative efforts.
    J Surg Oncol. 2015;112:183-7.
    PubMed     Text format     Abstract available


    July 2015
  46. BERTOLLI E, Bevilacqua JL, Molina AS, de Macedo MP, et al
    Popliteal sentinel lymph node involvement in melanoma patients.
    J Surg Oncol. 2015 Jul 31. doi: 10.1002/jso.23978.
    PubMed     Text format     Abstract available


    June 2015
  47. DOUSSOT A, Nardin C, Takaki H, Litchman TD, et al
    Liver resection and ablation for metastatic melanoma: A single center experience.
    J Surg Oncol. 2015 Jun 12. doi: 10.1002/jso.23929.
    PubMed     Text format     Abstract available


  48. HE M, Lovell J, Ng BL, Spillane J, et al
    Post-operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre-operative treatment and elective indication.
    J Surg Oncol. 2015;111:980-4.
    PubMed     Text format     Abstract available


    May 2015
  49. FANG Y, Chen X, Bai Q, Qin C, et al
    IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL.
    J Surg Oncol. 2015 May 18. doi: 10.1002/jso.23930.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: